Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Published:2011-02-16 Issue:3 Volume:30 Page:1065-1073
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Millward Michael,Mainwaring Paul,Mita Alain,Federico Kristine,Lloyd G. K.,Reddinger Natasha,Nawrocki Steffan,Mita Monica,Spear Matthew A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-011-9642-4.pdf

Reference28 articles.

1. Denekamp J (1982) Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer 45:136–9

2. Denekamp J (1991) The current status of targeting tumour vasculature as a means of cancer therapy: an overview. Int J Radiat Biol 60:401–8

3. Kakolyris S, Fox SB, Koukourakis M et al (2000) Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39. Br J Cancer 85:844–51

4. Escudier B, Eisen T, Stadler WM et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134

5. Motzer RJ, Hutson TE, Tomczak P et al (2007) Sunitinib versus Interferon Alfa in metastatic renal cellcarcinoma. N Engl J Med 356:115–124

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-delivery of Plinabulin and Tirapazamine boosts anti-tumor efficacy by simultaneously destroying tumor blood vessels and killing tumor cells;Biomaterials;2024-09

2. Tumor-targeting drug delivery regimens based on vascular disrupting agents;Precision Medicine and Engineering;2024-09

3. Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors;Expert Opinion on Pharmacotherapy;2024-05-23

4. A New Butoxy Substituted Indolediketopiperazine from the Marine Derived Fungus Aspergillus sp. 66may;Records of Natural Products;2024-03-25

5. Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents;Bioorganic Chemistry;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3